Skip to main content
Figure 1 | Trials

Figure 1

From: Effective recruitment of participants to a phase I study using the internet and publicity releases through charities and patient organisations: analysis of the adaptive study of IL-2 dose on regulatory T cells in type 1 diabetes (DILT1D)

Figure 1

Gender and duration of type 1 diabetes of eligible potential participants in DILT1D. a) Males and females were equally likely to decline to participate as to enrol, with similar proportions observed across the final trial outcomes regardless of recruitment source. b) Both the clinics and internet sources were effective in identifying newly diagnosed cases of T1D (less than 100-day duration) compared to the register. A total of 19 individuals were registered at diagnosis (clinics = 12, internet = 6, register = 1). The internet source identified the largest number of cases but the clinics source was the most efficient method of locating eligible participants. Median and interquartile range shown for 246 eligible participants with less than two years duration of type 1 diabetes.

Back to article page